heiBIB: Raab, Marc-Steffen

Raab, Marc-Steffen Dr. med.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (164)
deutsch (7)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

John, Lukas: Diagnostik beim multiplen Myelom / Lukas John, Niels Weinhold, Marc-Steffen Raab, 2025. - 6 S.
In: Onkologie, ISSN 1423-0240. (2025), early view, Seite 1-6
DOI: 10.1007/s00761-024-01652-6
Wirksamkeit und Sicherheit von Ciltacabtagene autoleucel : erfolgreicher Einsatz der CAR-T-Zelltherapie beim Multiplen Myelom / Herausgeber Prof. Dr. med. Martin Kortüm, Prof. Dr. med. Marc-Steffen Raab. -
Stuttgart: Thieme, Februar 2025. - 11 Seiten : Illustrationen, Diagramme
(Praxis Report)
Neelsen, Christian: Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma / Christian Neelsen, Christos Sachpekidis, Lukas John, Peter Neher, Elias Mai, Martin Grözinger, Danie… , 2025. - 11 S. : Illustrationen
In: European radiology, ISSN 1432-1084. 35(2025), 6, Seite 3576-3586
DOI: 10.1007/s00330-024-11191-8
Bärtsch, Marc-Andrea: Salvage autologous transplant in relapsed multiple myeloma : long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observations / Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S. Raab, Sandra Sauer, Maximilian Merz,… , 17 April 2025. - 8 S. : Diagramme
In: Blood, ISSN 1528-0020. 145(2025), 16 vom: Apr., Seite 1780-1787
DOI: 10.1182/blood.2024027342
Grab, Anna Luise: Pre-clinical assessment of SAR442257, a CD38/CD3xCD28 trispecific T cell engager in treatment of relapsed/refractory multiple myeloma / Anna Luise Grab, Peter S. Kim, Lukas John, Kamlesh Bisht, Hongfang Wang, Anja Baumann, Helgi Van de … , 20 May 2024. - 17 S.
In: Cells, ISSN 2073-4409. 13(2024), 10, Artikel-ID 879, Seite 1-17
DOI: 10.3390/cells13100879
Lutz, Raphael: Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy / Raphael Lutz, Florian Grünschläger, Malte Simon, Mohamed H. S. Awwad, Marcus Bauer, Schayan Yousefia… , 29 November 2024. - 18 S. : Diagramme, Illustrationen
In: Nature Communications, ISSN 2041-1723. 15(2024), Artikel-ID 10396, Seite 1-18
DOI: 10.1038/s41467-024-54543-0
Werly, Annika: Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma / Annika Werly, Mareike Hampel, Thomas Hielscher, Kosima Zuern, Sophia K. Schmidt, Alissa Visram, Marc… , 14 October 2024. - 4 S. : Illustrationen
In: Blood cancer journal, ISSN 2044-5385. 14(2024), Artikel-ID 176, Seite 1-4
DOI: 10.1038/s41408-024-01159-8
Leypoldt, Lisa: Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma / Lisa B. Leypoldt, MD, Diana Tichy, PhD, Britta Besemer, MD, Mathias Hanel, MD, Marc S. Raab, MD, Chr… , 2024. - 15 S.
In: Future oncology, ISSN 1744-8301. 20(2024), 39, Seite 3193-3207
DOI: 10.1080/14796694.2024.2402639
Kriegsmann, Katharina: CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients : results from the GMMG-HD6 multicenter phase III study / Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H. S. Awwad, Axel Benner, Uta Bertsch, Britta B… , 2024. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 38(2024), 7, Seite 1621-1625
DOI: 10.1038/s41375-024-02290-y
Kilian, Michael: The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance / Michael Kilian, Mirco J. Friedrich, Kevin Hai-Ning Lu, David Vonhören, Selina Jansky, Julius Michel,… , 3 May 2024
In: Science immunology, ISSN 2470-9468. 9(2024), 95, Artikel-ID eadj7970
DOI: 10.1126/sciimmunol.adj7970
Maura, Francesco: Genomic classification and individualized prognosis in multiple myeloma / Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M. Poos, Andriy Derkach, Kylee Mac… , January 9, 2024. - 12 S. : Illustrationen
In: Journal of clinical oncology, ISSN 1527-7755. 42(2024), 11 vom: Apr., Seite 1229-1240
DOI: 10.1200/JCO.23.01277
Frenking, Jan: EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma / Jan H. Frenking, Xiang Zhou, Vivien Wagner, Thomas Hielscher, Joseph Kauer, Elias K. Mai, Mirco J. F… , 07 October 2024. - 16 S. : Illustrationen
In: Journal for ImmunoTherapy of Cancer, ISSN 2051-1426. 12(2024), 10 vom: Okt., Artikel-ID e009220, Seite 1-16
DOI: 10.1136/jitc-2024-009220
Gezer, Deniz: Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma / Deniz Gezer, Melanie Schmitt Nogueira, Martin Kirschner, Tim H. Brümmendorf, Carsten Müller-Tidow, H… , October 2024. - 7 S. : Illustrationen
In: European journal of haematology, ISSN 1600-0609. 113(2024), 4 vom: Okt., Seite 465-471
DOI: 10.1111/ejh.14254
Cirrincione, Anthony: The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma / Anthony M. Cirrincione, Alexandra M. Poos, Bachisio Ziccheddu, Marcella Kaddoura, Marc-Andrea Bärtsc… , August 15, 2024. - 13 S.
In: Blood, ISSN 1528-0020. 144(2024), 7 vom: Aug., Seite 771-783
DOI: 10.1182/blood.2024024299
Zuern, Kosima: Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance / Kosima Zuern, Thomas Hielscher, Annika Werly, Iris Breitkreutz, Sandra Sauer, Marc S. Raab, Carsten … , 27 August 2024. - 7 S. : Illustrationen
In: Blood cancer journal, ISSN 2044-5385. 14(2024), Artikel-ID 148, Seite 1-7
DOI: 10.1038/s41408-024-01126-3
Seckinger, Anja: Molecular long-term analysis of the GMMG-HD4 trial in multiple myeloma$patterns of Association of Chromosomal Aberrations with response and proliferation determining survival in selecting treatments in view of limited resources in low- and middle-income countries / Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Uta Bertsch, Manuela… , 11 June 2024. - 19 S. : Illustrationen
In: International journal of molecular sciences, ISSN 1422-0067. 25(2024), 12, Artikel-ID 6431, Seite 1-19
DOI: 10.3390/ijms25126431
Sauer, Sandra: Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany / Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin S… , 14 March 2024. - 10 S. : Illustrationen
In: Bone marrow transplantation, ISSN 1476-5365. 59(2024), 6, Seite 880-889
DOI: 10.1038/s41409-024-02208-3
Sachpekidis, Christos: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in (18F)FDG PET/CT predicts survival in multiple myeloma / Christos Sachpekidis, Olof Enqvist, Johannes Ulén, Annette Kopp-Schneider, Leyun Pan, Elias K. Mai, … , 08 March 2024. - 15 S. : Illustrationen
In: European journal of nuclear medicine and molecular imaging, ISSN 1619-7089. 51(2024), 8, Seite 2293-2307
DOI: 10.1007/s00259-024-06668-z
Raab, Marc-Steffen: Venetoclax in myeloma : to B, or not to B / Marc S. Raab, January 4 2024. - 2 S. : Illustrationen
In: Blood, ISSN 1528-0020. 143(2024), 1 vom: Jan., Seite 4-5
DOI: 10.1182/blood.2023022535
Leypoldt, Lisa: Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the treatment of high-risk newly diagnosed multiple myeloma / Lisa B. Leypoldt, MD, Diana Tichy, MD, Britta Besemer, MD, Mathias Hänel, MD, Marc S. Raab, MD, Chri… , January 2024. - 21 S.
In: Journal of clinical oncology, ISSN 1527-7755. 42(2024), 1 vom: Jan., Seite 26-37
DOI: 10.1200/JCO.23.01696
Schreiner, Sarah: Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma / Sarah Schreiner, Natalie Berghaus, Alexandra M. Poos, Marc S. Raab, Britta Besemer, Roland Fenk, Har… , 11 Jan 2024. - 9 S. : Illustrationen
In: Amyloid, ISSN 1744-2818. 31(2024), 2, Seite 86-94
DOI: 10.1080/13506129.2023.2295221
Mai, Elias K.: Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial / Elias K Mai, Hartmut Goldschmidt, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Julia Krzyk… , February 2024. - 13 S.
In: The lancet, ISSN 2352-3026. 11(2024), 2, Seite e101-e113
DOI: 10.1016/S2352-3026(23)00366-6
Riedhammer, Christine: Real-world analysis of teclistamab in 123 RRMM patients from Germany / C. Riedhammer, F. Bassermann, B. Besemer, M. Bewarder, F. Brunner, A. Carpinteiro, H. Einsele, J. Fa… , 20 January 2024. - 7 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 38(2024), 2, Seite 365-371
DOI: 10.1038/s41375-024-02154-5
Riedhammer, Christine: Real-world analysis of Teclistamab in 115 RRMM patients from Germany / Christine Riedhammer, Florian Bassermann, Britta Besemer, Moritz Bewarder, Franziska Brunner, Alexan… , 2023 : Diagramme
In: Blood, ISSN 1528-0020. 142(2023), Supplement 1, Artikel-ID 3329
DOI: 10.1182/blood-2023-180032
Kauer, Joseph: Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients : a single centre experience from the GMMG-HD6 and -HD7 trials / Joseph Kauer, Emma P. Freundt, Anita Schmitt, Niels Weinhold, Elias K. Mai, Carsten Müller-Tidow, Ha… , 21 November 2023. - 11 S. : Illustrationen
In: BMC cancer, ISSN 1471-2407. 23(2023), Artikel-ID 1132, Seite 1-11
DOI: 10.1186/s12885-023-11507-9
Mai, Elias K.: Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients / Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Sonja Zweegman, Marc S. Raab, Markus… , 07 December 2023. - 8 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. (2023), Seite 1-8
DOI: 10.1038/s41375-023-02105-6
Emde-Rajaratnam, Martina: RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma / Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, Hans Salwender, Uta Bertsch, Christoph Scheid… , 15 November 2023. - 18 S. : Illustrationen
In: Frontiers in immunology, ISSN 1664-3224. 14(2023) vom: Nov., Artikel-ID 1286700, Seite 1-18
DOI: 10.3389/fimmu.2023.1286700
John, Lukas: Idecabtagene vicleucel is well tolerated and effective in relapsed/refractory myeloma patients with prior allogeneic stem cell transplantation / Lukas John, Sandra Sauer, Ute Hegenbart, Peter Dreger, Michael Hundemer, Carsten Müller-Tidow, Anita… , October 2023. - 6 S.
In: Transplantation and cellular therapy, ISSN 2666-6367. 29(2023), 10 vom: Okt., Seite 609.e1-609.e6
DOI: 10.1016/j.jtct.2023.06.010
John, Lukas: Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level / Lukas John, Alexandra M. Poos, Alexander Brobeil, Carolina Schinke, Stefanie Huhn, Nina Prokoph, Rap… , 17 August 2023. - 17 S.
In: Nature Communications, ISSN 2041-1723. 14(2023), Artikel-ID 5011, Seite 1-17
DOI: 10.1038/s41467-023-40584-4
Haertle, Larissa: Single-nucleotide variants and epimutations induce proteasome inhibitor resistance in multiple myeloma / Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou, Michal Simicek, Cornelia … , January 1 2023. - 10 S. : Illustrationen, Diagramme
In: Clinical cancer research, ISSN 1557-3265. 29(2023), 1, Seite 279-288
DOI: 10.1158/1078-0432.CCR-22-1161
Macauda, Angelica: Identification of novel genetic loci for risk of multiple myeloma by functional annotation / Angelica Macauda, Klara Briem, Alyssa Clay-Gilmour, Wendy Cozen, Asta Försti, Matteo Giaccherini, Ch… , 18 September 2023. - 4 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 37(2023), 11, Seite 2326-2329
DOI: 10.1038/s41375-023-02022-8
Zhao, Duoduo: The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations / Duoduo Zhao, Christian Rohde, Stefanie Göllner, Fengbiao Zhou, Cornelius Pauli, Maximilian Felix Bla… , 16 October 2023. - 6 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 37(2023), Seite 2526-2531
DOI: 10.1038/s41375-023-02060-2
Köhrer, Sebastian: High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders / Sebastian Köhrer, Tobias Dittrich, Martin Schorb, Niels Weinhold, Isabella Haberbosch, Mandy Börmel,… , 11 October 2023. - 11 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 37(2023), 12, Seite 2468-2478
DOI: 10.1038/s41375-023-02056-y
Poos, Alexandra: Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis / Alexandra M. Poos, Nina Prokoph, Moritz J. Przybilla, Jan-Philipp Mallm, Simon Steiger, Isabelle Seu… , 9 November 2023. - 14 S.
In: Blood, ISSN 1528-0020. 142(2023), 19, Seite 1633-1646
DOI: 10.1182/blood.2023019758
Leypoldt, Lisa: Daratumumab, Bortezomib, and Dexamethasone for treatment of patients with relapsed or refractory multiple myeloma and severe renal impairment : results from the phase 2 GMMG-DANTE trial / Lisa B. Leypoldt, Maria Gavriatopoulou, Britta Besemer, Hans Salwender, Marc S. Raab, Axel Nogai, Cy… , 2023. - 13 S.
In: Cancers, ISSN 2072-6694. 15(2023), 18, Artikel-ID 4667, Seite 1-13
DOI: 10.3390/cancers15184667
Dapunt, Ulrike A.: A precision-based exercise program for patients with multiple myeloma / Ulrike Dapunt, Pauline Ehret, Jean-Luc Paratte, Rea Maria Kuehl, Joachim Wiskemann, Dirk Jäger, Cars… , 20 September 2023. - 8 S. : Illustrationen
In: European journal of haematology, ISSN 1600-0609. 111(2023), 6, Seite 930-937
DOI: 10.1111/ejh.14106
Giesen, Nicola: A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma / Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M. Poos, Britta Besemer, Kaya Miah, Axel… , April 6, 2023. - 6 S.
In: Blood, ISSN 1528-0020. 141(2023), 14 vom: Apr., Seite 1685-1690
DOI: 10.1182/blood.2022017789
John, Lukas: Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma / Lukas John, Kaya Miah, Axel Benner, Elias K. Mai, Katharina Kriegsmann, Michael Hundemer, Dorothee K… , 21 April 2023. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 13(2023) vom: Apr., Artikel-ID 1078725, Seite 1-9
DOI: 10.3389/fonc.2023.1078725
Friedrich, Mirco: The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients / Mirco J. Friedrich, Paola Neri, Niklas Kehl, Julius Michel, Simon Steiger, Michael Kilian, Noémie Le… , 10 April 2023. - 21 S.
In: Cancer cell, ISSN 1878-3686. 41(2023), 4, Seite 711-725.e1-e6
DOI: 10.1016/j.ccell.2023.02.008
Kriegsmann, Katharina: Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM / Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias K. Mai, Marc S. Raab, Hans J. Salwender, Ro… , January 27, 2023. - 5 S.
In: Blood advances, ISSN 2473-9537. 7(2023), 3 vom: Jan., Seite 379-383
DOI: 10.1182/bloodadvances.2022008005
Mai, Elias K.: Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma / Elias K. Mai, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja C. Weisel, Uta Ber… , 04 January 2023. - 9 S.
In: Blood cancer journal, ISSN 2044-5385. 13(2023), 1, Artikel-ID 1, Seite 1-9
DOI: 10.1038/s41408-022-00772-9
Schjesvold, Fredrik: Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma / Fredrik Schjesvold, Bruno Paiva, Vincent Ribrag, Paula Rodriguez-Otero, Jesus F. San-Miguel, Pawel R… , 2023. - 12 S.
In: Clinical lymphoma, myeloma & leukemia, ISSN 2152-2669. 23(2023), 1 vom: Jan., Seite e59-e70
DOI: 10.1016/j.clml.2022.10.006
Goldschmidt, Hartmut: TRANSCAN V - iMMunocell: Entwicklung minimal-invasiver Verfahren zur Identifikation von Smouldering Myelom (SMM) Patienten : Schlussbericht : Laufzeit (Beginn und Ende): 01.09.2018-31.08.2022 / Autoren: Prof. Hartmut Goldschmidt, Prof. Marc-Steffen Raab, Dr. Niels Weinhold, Dr. Anna Luise Grab… . -
Heidelberg: Universität Heidelberg, Medizinische Fakultät und Universitätsklinikum Heidelberg, Medizinische Klinik - Innere Medizin V - Sektion Multiples Myelom, [2022?]. - 1 Online-Ressource (17 Seiten, 1,28 MB) : Diagramme
DOI: 10.2314/KXP:1881459705
Schinke, Carolina: Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level / Carolina Schinke, Alexandra M. Poos, Michael Bauer, Lukas John, Sarah Johnson, Shayu Deshpande, Luis… , 22 November 2022. - 11 S.
In: Blood advances, ISSN 2473-9537. 6(2022), 22, Seite 5873-5883
DOI: 10.1182/bloodadvances.2022007217
Giesen, Nicola: Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities / Nicola Giesen, Nagarajan Paramasivam, Umut H. Toprak, Daniel Huebschmann, Jing Xu, Sebastian Uhrig, … , August 2022. - 11 S.
In: Haematologica, ISSN 1592-8721. 107(2022), 8, Seite 1891-1901
DOI: 10.3324/haematol.2021.279360
Termini, Rosalinda: Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma / Rosalinda Termini, David Žihala, Evangelos Terpos, Albert Perez-Montaña, Tomáš Jelínek, Marc Raab, N… , 1 November 2022. - 11 S.
In: Clinical cancer research, ISSN 1557-3265. 28(2022), 21, Seite 4771-4781
DOI: 10.1158/1078-0432.CCR-22-1594
Darawshi, Odai: An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma / Odai Darawshi, Barbara Muz, Shiri Gershon Naamat, Bellam Praveen, Mohamed Mahameed, Karin Goldberg, … , 18 November 2022. - 12 S.
In: Cell death & disease, ISSN 2041-4889. 13(2022), 11, Artikel-ID 969, Seite 1-12
DOI: 10.1038/s41419-022-05421-4
Kehl, Niklas: IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells / Niklas Kehl, Michael Kilian, Julius Michel, Tim R. Wagner, Sebastian Uhrig, Alexander Brobeil, Lilli… , October 17, 2022. - 9 S.
In: Journal for ImmunoTherapy of Cancer, ISSN 2051-1426. 10(2022), 10, Artikel-ID e005815, Seite 1-9
DOI: 10.1136/jitc-2022-005815
German Speaking Myeloma Multicenter Group: Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial / Hartmut Goldschmidt, Elias K Mai, Uta Bertsch, Roland Fenk, Eva Nievergall, Diana Tichy, Britta Bese… , 31 October 2022. - 12 S.
In: The lancet, ISSN 2352-3026. 9(2022), 11, Seite e810-e821
DOI: 10.1016/S2352-3026(22)00263-0
Heinemann, Luca: Inhibiting PI3K-AKT-mTOR signaling in multiple myeloma-associated mesenchymal stem cells impedes the proliferation of multiple myeloma cells / Luca Heinemann, Klara Maria Möllers, Helal Mohammed Mohammed Ahmed, Lanying Wei, Kaiyan Sun, Subbaia… , 20 June 2022. - 11 S.
In: Frontiers in oncology, ISSN 2234-943X. 12(2022), Artikel-ID 874325, Seite 1-11
DOI: 10.3389/fonc.2022.874325
Awwad, Mohamed: Selective elimination of immunosuppressive T cells in patients with multiple myeloma / Mohamed H. S. Awwad, Abdelrahman Mahmoud, Heiko Bruns, Hakim Echchannaoui, Katharina Kriegsmann, Rap… , 17 February 2021. - 14 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 9, Seite 2602-2615
DOI: 10.1038/s41375-021-01172-x
Rasche, Leo: Novel immunotherapies in multiple myeloma : chances and challenges / Leo Rasche, Ralph Wäsch, Markus Munder, Hartmut Goldschmidt and Marc S. Raab, July 1, 2021. - 11 S.
In: Haematologica, ISSN 1592-8721. 106(2021), 10, Seite 2555-2565
DOI: 10.3324/haematol.2020.266858
Klein, Eva-Maria: Prognostic impact of serum free light chain ratio normalization in patients with multiple myeloma treated within the GMMG-MM5 trial / Eva-Maria Klein, Diana Tichy, Hans J. Salwender, Elias K. Mai, Jan Duerig, Katja C. Weisel, Axel Ben… , 28 September 2021. - 16 S.
In: Cancers, ISSN 2072-6694. 13(2021), 19, Artikel-ID 4856, Seite 1-16
DOI: 10.3390/cancers13194856
Khandanpour, Cyrus: Prevalence of the GFI1-36N SNP in multiple myeloma patients and its impact on the prognosis / Cyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, Marc S. Raab, Niels Weinhold, Anja … , 25 October 2021. - 8 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 25. Okt., Artikel-ID 757664, Seite 1-8
DOI: 10.3389/fonc.2021.757664
Tirier, Stephan Marius: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics / Stephan M. Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M. Poos, Mohamed H. S. Awwad, Nicola … , 29 November 2021. - 16 S.
In: Nature Communications, ISSN 2041-1723. 12(2021), Artikel-ID 6960, Seite 1-16
DOI: 10.1038/s41467-021-26951-z
Weinhold, Niels: Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients / Niels Weinhold, Hans J. Salwender, David A. Cairns, Marc S. Raab, George Waldron, Igor W. Blau, Uta … , October, 2021. - 5 S.
In: Haematologica, ISSN 1592-8721. 106(2021), 10, Seite 2754-2758
DOI: 10.3324/haematol.2021.278888
Sachpekidis, Christos: The prognostic significance of (18F)FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs) / Christos Sachpekidis, Maximilian Merz, Marc-Steffen Raab, Uta Bertsch, Vivienn Weru, Annette Kopp-Sc… , 09 October 2021. - 12 S.
In: EJNMMI Research, ISSN 2191-219X. 11(2021), Artikel-ID 100, Seite 1-12
DOI: 10.1186/s13550-021-00846-y
Bärtsch, Marc-Andrea: Carfilzomib, lenalidomide, and dexamethasone followed by salvage autologous stem cell transplant with or without maintenance for relapsed or refractory multiple myeloma / Marc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, Sandra Sauer, Iris Breitkreutz, Karin Jo… , 20 September 2021. - 13 S.
In: Cancers, ISSN 2072-6694. 13(2021), 18, special issue, Artikel-ID 4706, Seite 1-13
DOI: 10.3390/cancers13184706
Tremblay, Gabriel: Quality of life analyses in patients with multiple myeloma : results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study / Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Ka… , 06 September 2021. - 10 S.
In: BMC cancer, ISSN 1471-2407. 21(2021), Artikel-ID 993, Seite 1-10
DOI: 10.1186/s12885-021-08453-9
Lutz, Raphael: Therapeutic advances propelled by deciphering tumor biology and immunology-highlights of the 8th Heidelberg Myeloma Workshop / Raphael Lutz, Mirco Friedrich, Marc Steffen Raab, Niels Weinhold and Hartmut Goldschmidt, 18 August 2021. - 13 S.
In: Cancers, ISSN 2072-6694. 13(2021), 16, Artikel-ID 4135, Seite 1-13
DOI: 10.3390/cancers13164135
Mai, Elias K.: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age / Elias K. Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, M… , 2021. - 14 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 3, Seite 809-822
DOI: 10.1038/s41375-020-0976-9
John, Lukas: Pathway-directed therapy in multiple myeloma / Lukas John, Maria Theresa Krauth, Klaus Podar and Marc-Steffen Raab, 1 April 2021. - 19 S.
In: Cancers, ISSN 2072-6694. 13(2021), 7, Artikel-ID 1668, Seite 1-19
DOI: 10.3390/cancers13071668
Figueroa Vazquez, Vianihuini: HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells / Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Anikó Pálf… , 2021. - 13 S.
In: Molecular cancer therapeutics, ISSN 1538-8514. 20(2021), 2, Seite 367-378
DOI: 10.1158/1535-7163.MCT-20-0287
Bärtsch, Marc-Andrea: Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma / Marc-Andrea Baertsch, Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Markus Munder,… , 07 January 2021. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 11(2021), Artikel-ID 1, Seite 1-10
DOI: 10.1038/s41408-020-00390-3
Sellner, Leopold: B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma : clinical experience and future perspectives / Leopold Sellner, Fuli Fan, Nicola Giesen, Maria-Luisa Schubert, Hartmut Goldschmidt, Carsten Müller-… , 2020. - 13 S.
In: International journal of cancer, ISSN 1097-0215. 147(2020), 8, Seite 2029-2041
DOI: 10.1002/ijc.33002
Goldschmidt, Hartmut: Response-adapted lenalidomide maintenance in newly diagnosed myeloma : results from the phase III GMMG-MM5 trial / Hartmut Goldschmidt, Elias K. Mai, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, Uta … , 7 February 2020. - 13 S.
In: Leukemia, ISSN 1476-5551. 34(2020), 7, Seite 1853-1865
DOI: 10.1038/s41375-020-0724-1
Hájek, Roman: Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma : external validation in a retrospective chart review / Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, Michel Delforge, Lucy DeCosta, Marc S. Raab, W… , July 14, 2020. - 10 S.
In: BMJ open, ISSN 2044-6055. 10(2020), 7, Artikel-ID e034209, Seite 1-10
DOI: 10.1136/bmjopen-2019-034209
Kriegsmann, Katharina: Comparison of NGS and MFC methods : key metrics in multiple myeloma MRD assessment / Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, Philipp Reichert, Calin-Petru Mant… , 18 August 2020. - 15 S.
In: Cancers, ISSN 2072-6694. 12(2020,8) Artikel-Nummer 2322, 15 Seiten
DOI: 10.3390/cancers12082322
Vij, Ravi: First-in-human phase I study of ABBV-838, an antibody-drug conjugate targeting SLAMF7/CS1 in patients with relapsed and refractory multiple myeloma / Ravi Vij, Rajneesh Nath, Daniel E.H. Afar, María-Victoria Mateos, Jesús G. Berdeja, Marc S. Raab, An… , May 2020. - 10 S.
In: Clinical cancer research, ISSN 1557-3265. 26(2020), 10, Seite 2308-2317
DOI: 10.1158/1078-0432.CCR-19-1431
Hájek, Roman: Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters : the Czech Myeloma Group model / Roman Hájek, Viera Sandecka, Ivan Špička, Marc Raab, Hartmut Goldschmidt, Susanne Beck, Jiří Minařík… , 12 March 2020. - 9 S.
In: British journal of haematology, ISSN 1365-2141. 190(2020), 2, Seite 189-197
DOI: 10.1111/bjh.16572
Goldschmidt, Hartmut: Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma : the randomized GMMG phase III trial ReLApsE / Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thom… , 21 July 2020. - 11 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 4, Seite 1134-1144
DOI: 10.1038/s41375-020-0948-0
Raab, Marc-Steffen: Y MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma : a first-in-human, multicentre, phase 1-2a trial / Marc S. Raab, Monika Engelhardt, Antje Blank, Hartmut Goldschmidt, Hermine Agis, Igor W. Blau, Herma… , 11 March 2020. - 14 S.
In: The lancet, ISSN 2352-3026. 7(2020), 5, Seite e381-e394
DOI: 10.1016/S2352-3026(19)30249-2
Merz, Maximilian: Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma / Maximilian Merz, Thomas Hielscher, David Schult, Elias K. Mai, Marc S. Raab, Jens Hillengass, Anja S… , [2020]. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 34(2020), 4, Seite 1192-1196
DOI: 10.1038/s41375-019-0634-2
Merz, Maximilian: Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma / Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Anna Jauch, Sandra Sau… , 27 August 2019. - 5 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019,9) Artikel-Nummer 71, 5 Seiten
DOI: 10.1038/s41408-019-0235-3
Sachpekidis, Christos: Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma : letters to the editor / Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, Anna Jauch, Marc-Steffen Raab, Sandra… , September 2019. - 4 S.
In: Haematologica, ISSN 1592-8721. 104(2019), 9, Seite e420-e423
DOI: 10.3324/haematol.2018.213041
Brand, Frank: FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas / Frank Brand, Alisa Förster, Anne Christians, Martin Bucher, Carina M. Thomé, Marc S. Raab, Manfred W… , 2020. - 18 S.
In: Acta neuropathologica, ISSN 1432-0533. 139(2020), 1, Seite 175-192
DOI: 10.1007/s00401-019-02067-z
Mohty, Mohamad: Understanding mortality in multiple myeloma : findings of a european retrospective chart review / Mohamad Mohty, Michele Cavo, Leah Fink, Sebastian Gonzalez‐McQuire, Henri Leleu, Maria-Victoria Mate… , 21 May 2019. - 9 S.
In: European journal of haematology, ISSN 1600-0609. 103(2019), 2, Seite 107-115
DOI: 10.1111/ejh.13264
Raab, Marc-Steffen: The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma / Marc S. Raab, Sheeba K. Thomas, Enrique M. Ocio, Andreas Guenther, Yeow-Tee Goh, Moshe Talpaz, Nicol… , 15 May 2019. - 10 S.
In: Leukemia, ISSN 1476-5551. 33(2019), 12, Seite 2924-2933
DOI: 10.1038/s41375-019-0482-0
Chari, Ajai: Oral selinexor-dexamethasone for triple-class refractory multiple myeloma / Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Andrew J. Yee, Carol A. Huff, Philippe… , August 22, 2019. - 11 S.
In: The New England journal of medicine, ISSN 1533-4406. 381(2019), 8, Seite 727-738
DOI: 10.1056/NEJMoa1903455
Bärtsch, Marc-Andrea: Meeting report of the 7th Heidelberg Myeloma Workshop : today and tomorrow / M.A. Baertsch, R. Lutz, M.S. Raab, N. Weinhold, H. Goldschmidt, 12 August 2019. - 11 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 145(2019), 10, Seite 2445-2455
DOI: 10.1007/s00432-019-02998-w
Hose, Dirk: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial / Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid… . -
London: BioMed Central, 09 Aug. 2019. - 1 Online-Ressource (12 Seiten)
Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… . -
London: BioMed Central, 2019. - 1 Online-Ressource (11 Seiten)
Campa, Daniele: Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival : an IMMEnSE study / Daniele Campa, Alessandro Martino, Angelica Macauda, Marek Dudziński, Anna Suska, Agnieszka Druzd-Si… , 11 January 2019. - 9 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 60(2019), 7, Seite 1803-1811
DOI: 10.1080/10428194.2018.1551536
Hose, Dirk: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial / Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid… , 26 June 2019. - 12 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 12(2019), Artikel-ID 65, Seite 1-12
DOI: 10.1186/s13045-019-0750-5
Mai, Elias K.: Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma / Elias K. Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J. Salwender, Markus Munder, Chris… , 2019. - 4 S.
In: Leukemia, ISSN 1476-5551. 33(2019), 1, Seite 258-261
DOI: 10.1038/s41375-018-0195-9
Salwender, Hans: Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma / Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Ma… , 28 May 2019. - 11 S.
In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 504, 11 Seiten
DOI: 10.1186/s12885-019-5600-x
Breitkreutz, Iris: Erratum zu : Primärtherapie beim Multiplen Myelom / I. Breitkreutz, M. Raab, H. Goldschmidt, 18. März 2019. - 1 S.
In: Der Internist, ISSN 1432-1289. 60(2019), 5, Seite 552-552
DOI: 10.1007/s00108-019-0581-z
Rasche, Leo: The impact of tumor heterogeneity on diagnostics and novel therapeutic strategies in multiple myeloma / Leo Rasche, K. Martin Kortüm, Marc S. Raab and Niels Weinhold, 12 March 2019. - 14 S. : Illustrationen
In: International journal of molecular sciences, ISSN 1422-0067. 20 (2019,5) Artikel-Nummer 1248, Seite 1-14, 14 Seiten
DOI: 10.3390/ijms20051248
Kriegsmann, Katharina: Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients / Katharina Kriegsmann, Marc-Andrea Baertsch, Mohamed H. S. Awwad, Maximilian Merz, Dirk Hose, Anja Se… , 29 January 2019. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019), 2, Artikel-ID 13, Seite 1-10
DOI: 10.1038/s41408-019-0174-z
Seckinger, Anja: Treatment response and long-term survival in multiple myeloma in the GMMG-HD4 trial : neither profit all molecular entities alike, nor are remissions to different regimen equal / Anja Seckinger, Hans Jürgen Salwender, MD, Hans Martin, MD, Christof Scheid, Thomas Hielscher, Uta B… , 29 November 2018. - 4 S.
In: Blood, ISSN 1528-0020. 132(2018), Supplement_1, Artikel-ID 4485, Seite 1-4
DOI: 10.1182/blood-2018-99-113284
Awwad, Mohamed: The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma / Mohamed H.S. Awwad, Katharina Kriegsmann, Julian Plaumann, Michael Benn, Jens Hillengass, Marc S. Ra… , 01 Aug 2018. - 11 S.
In: OncoImmunology, ISSN 2162-402X. 7(2018), 10, Artikel-ID e1486356, Seite 1-11
DOI: 10.1080/2162402X.2018.1486356
Plaumann, Julian: IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells / Julian Plaumann, Melanie Engelhardt, Mohamed H. S. Awwad, Hakim Echchannaoui, Eva Amman, Marc S. Raa… , 20 August 2018. - 13 S.
In: Cancer immunology immunotherapy, ISSN 1432-0851. 67(2018), 11, Seite 1695-1707
DOI: 10.1007/s00262-018-2230-0
Merz, Maximilian: Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance / Maximilian Merz, Thomas Hielscher, Korbinian Hoffmann, Anja Seckinger, Dirk Hose, Marc S. Raab, Jens… , 6 July 2018. - 3 S.
In: Leukemia, ISSN 1476-5551. 32(2018), 12, Seite 2717-2719
DOI: 10.1038/s41375-018-0202-1
Dimopoulos, Meletios A.: Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma / Meletios A. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Philippe Moreau, Naoki Takezako, Mitsuo… , November 8, 2018. - 12 S.
In: The New England journal of medicine, ISSN 1533-4406. 379(2018), 19, Seite 1811-1822
DOI: 10.1056/NEJMoa1805762
Bochtler, Tilmann: Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma / Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, Martin Granzow, Korbinian Hoffmann, Alwin Kräme… , 2018. - 12 S.
In: Blood advances, ISSN 2473-9537. 2(2018), 20, Seite 2607-2618
DOI: 10.1182/bloodadvances.2018023200
Giesen, Nicola: Oncogene-induced senescence : a potential breakpoint mechanism against malignant transformation in plasma cell disorders / Nicola Lehners, Elena Ellert, Jing Xu, Jens Hillengass, Jonas Leichsenring, Albrecht Stenzinger, Har… , 04 Apr 2018. - 10 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 59(2018), 11, Seite 2660-2669
DOI: 10.1080/10428194.2018.1443450
Barrio, Santiago: Spectrum and functional validation of PSMB5 mutations in multiple myeloma / Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, Clara Barrio-Garcia, Nicola Lehners, Andrej Besse,… , 2019. - 10 S.
In: Leukemia, ISSN 1476-5551. 33(2019), 2, Seite 447-456
DOI: 10.1038/s41375-018-0216-8
Raab, Marc-Steffen: Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016 / Marc S. Raab, Leah Fink, Paul Schoen, Sebastian Gonzalez-McQuire, Alain Flinois, Michele Cavo, Maria… , 2019. - 4 S.
In: British journal of haematology, ISSN 1365-2141. 185(2019), 5, Seite 981-984
DOI: 10.1111/bjh.15680
Breitkreutz, Iris: The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma / Iris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, Scott Wilhelm, Patrick J. Hayden, Kennet… , 23 January 2018. - 11 S.
In: Annals of hematology, ISSN 1432-0584. 97(2018), 5, Seite 839-849
DOI: 10.1007/s00277-018-3237-5
Walker, Brian A.: A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis / Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, T. Cody Ashby, Michael Bauer, Fai… , 2019. - 12 S.
In: Leukemia, ISSN 1476-5551. 33(2019), 1, Seite 159-170
DOI: 10.1038/s41375-018-0196-8
Breitkreutz, Iris: Primärtherapie beim Multiplen Myelom : = / I. Breitkreutz, M. Raab, H. Goldschmidt, 2019. - 11 S.
In: Der Internist, ISSN 1432-1289. 60(2019), 1, Seite 23-33
DOI: 10.1007/s00108-018-0527-x
Walker, Brian A.: Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma / Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, T. Cody Ashby, Michael Bauer, Fai… , June 8, 2018. - 11 S.
In: Blood, ISSN 1528-0020. 132(2018), 6, Seite 587-597
DOI: 10.1182/blood-2018-03-840132
Goldschmidt, Hartmut: Bortezomib before and after high-dose therapy in myeloma : long-term results from the phase III HOVON-65/GMMG-HD4 trial / H. Goldschmidt, H.M Lokhorst, E.K. Mai, B. van der Holt, I.W. Blau, S. Zweegman, K.C. Weisel, E. Vel… , 2018. - 8 S.
In: Leukemia, ISSN 1476-5551. 32(2018), Seite 383-390
Seckinger, Anja: CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma : association with molecular entities, risk, survival, and mechanisms of upfront resistance / Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Mic… , 20 July 2018. - 15$
In: Frontiers in immunology, ISSN 1664-3224. 9(2018), Artikel-ID 1676, Seite 1-15
DOI: 10.3389/fimmu.2018.01676
Giesen, Nicola: Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation : impact of clinical risk factors and sustained response / Nicola Lehners, Natalia Becker, Axel Benner, Maria Pritsch, Martin Löpprich, Elias Karl Mai, Jens Hi… , 2018. - 10 S.
In: Cancer medicine, ISSN 2045-7634. 7(2018), 2, Seite 307-316
DOI: 10.1002/cam4.1283
Kriegsmann, Katharina: Potential therapeutic targets in plasma cell disorders : a flow cytometry study / Katharina Lisenko, Stefan Schönland, Ute Hegenbart, Katrin Wallenwein, Ute Braun, Elias K. Mai, Jens… , 2017. - 8 S.
In: Cytometry, ISSN 1552-4957. 92(2017), 2, Seite 145-152
DOI: 10.1002/cyto.b.21351
Xu, Jing: Molecular signaling in multiple myeloma : association of RAS/RAF mutations and MEK/ERK pathway activation / J. Xu, N. Pfarr, V. Endris, E.K. Mai, N.H. Md Hanafiah, N. Lehners, R. Penzel, W. Weichert, A.D. Ho,… , 15 May 2017. - 5 S.
In: Oncogenesis, ISSN 2157-9024. 6(2017), 5, Artikel-ID e337
DOI: 10.1038/oncsis.2017.36
Cosenza, Marco R.: Asymmetric centriole numbers at spindle poles cause chromosome missegregation in cancer / Marco R. Cosenza, Anna Cazzola, Annik Rossberg, Nicole L. Schieber, Gleb Konotop, Elena Bausch, Alla… , 22 August 2017. - 15 S.
In: Cell reports, ISSN 2211-1247. 20(2017), 8, Seite 1906-1920
DOI: 10.1016/j.celrep.2017.08.005
Merz, Maximilian: Meeting report of the 6th Heidelberg Myeloma Workshop : current status and developments in diagnosis and therapy of multiple myeloma / Maximilian Merz, Marc S. Raab, Hartmut Goldschmidt, Jens Hillengass. - 6 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 143(2017), 12, S. 2521-2526
DOI: 10.1007/s00432-017-2463-x
Merz, Maximilian: Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation / Maximilian Merz, Anna Jauch, Thomas Hielscher, Elias K. Mai, Anja Seckinger, Dirk Hose, Uta Bertsch,… , May 11, 2017. - 7 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 8, Seite 1432-1438
DOI: 10.3324/haematol.2017.168005
Petersen, Asger B.: Synthesis and formulation studies of griseofulvin analogues with improved solubility and metabolic stability / Asger B. Petersen, Nikolaj S. Andersen, Gleb Konotop, Nur Hafzan Md Hanafiah, Marc S. Raab, Alwin Kr… , 22 February 2017. - 8 S.
In: European journal of medicinal chemistry, ISSN 1768-3254. 130(2017), Seite 240-247
DOI: 10.1016/j.ejmech.2017.02.055
Claßen, Laura: Extracellular vesicles mediate intercellular communication : transfer of functionally active microRNAs by microvesicles into phagocytes / Laura Claßen, Lars-Oliver Tykocinski, Felix Wiedmann, Carolin Birr, Petra Schiller, Christine Tucher… , 30 June 2017. - 15 S.
In: European journal of immunology, ISSN 1521-4141. 47(2017), 9, Seite 1535-1549
DOI: 10.1002/eji.201646595
Bärtsch, Marc-Andrea: Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma : a case-based approach / Marc-Andrea Baertsch, Michael Hundemer, Jens Hillengass, Hartmut Goldschmidt, Marc S. Raab. - 4 S.
In: Hematological oncology, ISSN 1099-1069. 36(2018), 1, S. 258-261
DOI: 10.1002/hon.2473
Bärtsch, Marc-Andrea: Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice / Marc-Andrea Baertsch, Jens Hillengass, Joanna Blocka, Stefan Schönland, Ute Hegenbart, Hartmut Golds… . - 7 S.
In: Hematological oncology, ISSN 1099-1069. 36(2018), 1, S. 210-216
DOI: 10.1002/hon.2462
Natoni, Alessandro: E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271 / A. Natoni, T. a. G. Smith, N. Keane, C. McEllistrim, C. Connolly, A. Jha, M. Andrulis, E. Ellert, M.… . - 10 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 12, S. 2642-2651
DOI: 10.1038/leu.2017.123
Raab, Marc-Steffen: Oxygen bubbles to predict sensitivity to IMiDs / Marc S. Raab. - 3 S.
In: Blood, ISSN 1528-0020. 129(2017), 8, S. 923-925
DOI: 10.1182/blood-2017-01-760512
Petersen, Asger B.: Strategies for improving the solubility and metabolic stability of griseofulvin analogues / A. B. Petersen, G. Konotop, N. H. M. Hanafiah, P. Hammershøj, M. S. Raab, A. Krämer, M. H. Clausen, 28 March 2016. - 6 S.
In: European journal of medicinal chemistry, ISSN 1768-3254. 116(2016), Seite 210-215
DOI: 10.1016/j.ejmech.2016.03.071
Krämer, Isabelle: Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro / Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsc… , 31 May 2016. - 10 S.
In: OncoImmunology, ISSN 2162-402X. 5(2016,5) Artikel-Nummer e1139662, 10 seiten
DOI: 10.1080/2162402X.2016.1139662
Weinhold, Niels: Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma / Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlind… , March 2016. - 4 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 3, Seite e116-e119
DOI: 10.3324/haematol.2015.136929
Raab, Marc-Steffen: Spatially divergent clonal evolution in multiple myeloma : overcoming resistance to BRAF inhibition / Marc S. Raab, Nicola Lehners, Jing Xu, Anthony D. Ho, Peter Schirmacher, Hartmut Goldschmidt, and Mi… , April 28, 2016. - 3 S.
In: Blood, ISSN 1528-0020. 127(2016), 17, Seite 2155-2157
DOI: 10.1182/blood-2015-12-686782
Mai, Elias K.: Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma : long-term results from the phase III GMMG-HD2 trial / Elias K. Mai, Axel Benner, Uta Bertsch, Peter Brossart, Annette Hänel, Volker Kunzmann, Ralph Nauman… , 17 March 2016. - 11 S.
In: British journal of haematology, ISSN 1365-2141. 173(2016), 5, Seite 731-741
DOI: 10.1111/bjh.13994
Konotop, Gleb: Pharmacological inhibition of centrosome clustering by slingshot-mediated cofilin activation and actin cortex destabilization / Gleb Konotop, Elena Bausch, Tomoaki Nagai, Andrey Turchinovich, Natalia Becker, Axel Benner, Michael… , November 15, 2016. - 11 S.
In: Cancer research, ISSN 1538-7445. 76(2016), 22, Seite 6690-6700
DOI: 10.1158/0008-5472.CAN-16-1144
Bärtsch, Marc-Andrea: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma / Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, D… , 25 April 2016. - 10 S.
In: BMC cancer, ISSN 1471-2407. 16(2016) Artikel-Nummer 290, 10 Seiten
DOI: 10.1186/s12885-016-2321-2
Giesen, Nicola: Management of high-risk Myeloma : an evidence-based review of treatment strategies / Nicola Lehners, Patrick J. Hayden, Hartmut Goldschmidt & Marc-Steffen Raab, 4 July 2016. - 13 S.
In: Expert review of hematology, ISSN 1747-4094. 9(2016), 8, Seite 753-765
DOI: 10.1080/17474086.2016.1204908
Kortüm, Klaus Martin: Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes / K. Martin Kortüm, Elias K. Mai, Nur H. Hanafiah, Chang-Xi Shi, Yuan-Xiao Zhu, Laura Bruins, Santiago… , 25 July 2016. - 8 S.
In: Blood, ISSN 1528-0020. 128(2016), 9, Seite 1226-1233
DOI: 10.1182/blood-2016-02-698092
Mai, Elias K.: Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma : analyzing surrogates of tumour mass and biology / Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Michaela Hillengass, Bar… , 15 January 2016. - 10 S.
In: European radiology, ISSN 1432-1084. 26(2016), 11, Seite 3939-3948
DOI: 10.1007/s00330-015-4195-0
Raab, Marc-Steffen: Multiple myeloma : practice patterns across Europe / Marc S. Raab, Michele Cavo, Michel Delforge, Christoph Driessen, Leah Fink, Alain Flinois, Sebastian… , 13 June 2016. - 11 S.
In: British journal of haematology, ISSN 1365-2141. 175(2016), 1, Seite 66-76
DOI: 10.1111/bjh.14193
Yong, Kwee: Multiple myeloma : patient outcomes in real-world practice / Kwee Yong, Michel Delforge, Christoph Driessen, Leah Fink, Alain Flinois, Sebastian Gonzalez-McQuire… , 15 April 2016. - 13 S.
In: British journal of haematology, ISSN 1365-2141. 175(2016), 2, Seite 252-264
DOI: 10.1111/bjh.14213
Breitkreutz, Iris: Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function / Iris Breitkreutz, Natalia Becker, Axel. Benner, Florentina Kosely, Christoph Heining, Jens Hillengas… , 2016. - 8 S.
In: Hematological oncology, ISSN 1099-1069. 34(2016), 4, Seite 200-207
DOI: 10.1002/hon.2199
Merz, Maximilian: Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , December 2016. - 3 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 12, Seite e485-e487
DOI: 10.3324/haematol.2016.151266
Merz, Maximilian: Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma / Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Go… , 10 August 2016. - 5 S.
In: American journal of hematology, ISSN 1096-8652. 91(2016), 11, Seite E473-E477
DOI: 10.1002/ajh.24533
Bärtsch, Marc-Andrea: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma / Marc-Andrea Bärtsch, Jana Schlenzka, Elias Karl Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, … . -
London; Berlin; Heidelberg: BioMed Central; Springer, 2016. - 1 Online-Ressource (10 Seiten)
Fichtner, Sabrina: Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma / Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, Tobias Meißner, Brigitte Neuber, Fatime Krasniqi, M… , January 21, 2015. - 10 S.
In: Clinical cancer research, ISSN 1557-3265. 21(2015), 7, Seite 1712-1721
DOI: 10.1158/1078-0432.CCR-14-1618
Niesvizky, Ruben: Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma / Ruben Niesvizky, Ashraf Z. Badros, Luciano J. Costa, Scott A. Ely, Seema B. Singhal, Edward A. Stadt… , 15 May 2015. - 9 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 56(2015), 12, Seite 3320-3328
Keane, Niamh A.: Targeting the Pim kinases in multiple myeloma / NA Keane, M Reidy, A Natoni, MS Raab and M O'Dwyer, 17 July 2015. - 9 S.
In: Blood cancer journal, ISSN 2044-5385. 5(2015,5) Artikel-Nummer e325, 9 Seiten
DOI: 10.1038/bcj.2015.46
Wang, Lei: T cell-based targeted immunotherapies for patients with multiple myeloma / Lei Wang, Nan Jin, Anita Schmitt, Jochen Greiner, Georg Malcherek, Michael Hundemer, Jiju Mani, Dirk… , 2015. - 18 S.
In: International journal of cancer, ISSN 1097-0215. 136(2015), 8, Seite 1751-1768
DOI: 10.1002/ijc.29190
Mai, Elias K.: A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma / Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Marc S. Raab, Michaela H… , June 2015. - 8 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 6, Seite 818-825
DOI: 10.3324/haematol.2015.124115
Merz, Maximilian: Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , July 2015. - 6 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 7, Seite 964-969
DOI: 10.3324/haematol.2015.124347
Waizenegger, Jonas S.: Role of growth arrest-specific gene 6-Mer axis in multiple myeloma / JS Waizenegger, I Ben-Batalla, N Weinhold, T Meissner, M Wroblewski, M Janning, K Riecken, M Binder,… , 2015. - 10 S.
In: Leukemia, ISSN 1476-5551. 29(2015), 3, Seite 696-704
DOI: 10.1038/leu.2014.236
Richardson, Paul G.: Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma : final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study / Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej J. Jakubowiak, Marc S. Raab, Thierry … . - 12 S.
In: The lancet, ISSN 2352-3026. 2(2015), 12, S. e516-e527
DOI: 10.1016/S2352-3026(15)00197-0
Raab, Marc-Steffen: Neue Therapieansätze bei malignen Plasmazellerkrankungen / vorgelegt von Marc-Steffen Raab, 2014 [ersch.] 2015. - 99 Bl. : Ill., graph. Darst.
Mai, Elias K.: Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma / E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T… , 2015
In: Leukemia, ISSN 1476-5551. 29(2015), 8, Seite 1721-1729
DOI: 10.1038/leu.2015.80
Merz, Maximilian: Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma / M. Merz, T. Hielscher, B. Wagner, S. Sauer, S. Shah, M. S. Raab, A. Jauch, K. Neben, D. Hose, G. Ege… , [2014]. - 7 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 9, Seite 1902-1908
DOI: 10.1038/leu.2014.75
Wagner, Verena: Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 / Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreut… , September 26, 2014. - 14 S.
In: OncoTarget, ISSN 1949-2553. 5(2014), 21, Seite 10237-10250
DOI: 10.18632/oncotarget.2529
Goldschmidt, Hartmut: Strategien beim rezidivierten/refraktären multiplen Myelom / H. Goldschmidt, M.-S. Raab, K. Neben, K. Weisel, I.G.H. Schmidt-Wolf. - 7 S.
In: Der Onkologe, ISSN 1433-0415. 20(2014), 3, S. 250-256
DOI: 10.1007/s00761-013-2573-2
Andrulis, Mindaugas: Expression of Mucin-1 in multiple myeloma and its precursors : correlation with glycosylation and subcellular localization / Mindaugas Andrulis, Elena Ellert, Ulla Mandel, Henrik Clausen, Nicola Lehners, Marc-Steffen Raab, Ha… , May 2014. - 8 S.
In: Histopathology, ISSN 1365-2559. 64(2014), 6, Seite 799-806
DOI: 10.1111/his.12330
Breitkreutz, Iris: Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure / I. Breitkreutz, C. Heiss, A. Perne, J. Beimler, D. Jäger, G. Egerer, A. D. Ho, K. Neben, M. Zeier, H… , 2014. - 5 S.
In: Bone marrow transplantation, ISSN 1476-5365. 49(2014), 11, Seite 1371-1375
DOI: 10.1038/bmt.2014.165
Richardson, Paul G.: Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma / Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab, Thierry Fac… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 74278, 1 S.
Raab, Marc-Steffen: Signaling pathway profiling in multiple myeloma / Marc S. Raab, Jing Xu, Thomas Hielscher, Nicola Lehners, Elena Ellert, Anthony D. Ho, Peter Schirmac… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 69318, 1 S.
Merz, Maximilian: Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents / Merz, M.; Neben, K.; Raab, M. S.; Sauer, S.; Egerer, G.; Hundemer, M.; Hose, D.; Kunz, C.; Heiss, C.… , 2014. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 25(2014), 1, Seite 189-195
DOI: 10.1093/annonc/mdt509
Neben, Kai: Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load / Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Gra… , October 21, 2013. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 31(2013), 34, Seite 4325-4332
DOI: 10.1200/JCO.2012.48.4923
Sellner, Leopold: Autologous retransplantation for patients with recurrent multiple myeloma : a single-center experience with 200 patients / Leopold Sellner, Christiane Heiss, Axel Benner, Marc S. Raab, Jens Hillengass, Dirk Hose, Nicola Leh… , April 10, 2013. - 9 S.
In: Cancer, ISSN 1097-0142. 119(2013), 13, Seite 2438-2446
DOI: 10.1002/cncr.28104
Yordanova, Anna: Sorafenib in patients with refractory or recurrent multiple myeloma / Anna Yordanova, Dirk Hose, Kai Neben, Mathias Witzens-Harig, Ines Gütgemann, Marc-Steffen Raab, Thom… , 15 March 2013. - 4 S.
In: Hematological oncology, ISSN 1099-1069. 31(2013), 4, Seite 197-200
DOI: 10.1002/hon.2043
Schmitt, Stefan: Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation / S. Schmitt, T. Hielscher, C. Baldus, K. Neben, G. Egerer, J. Hillengaß, M. Raab, D. Hose, A.D. Ho, R… , 25 April 2013. - 8 S.
In: International journal of hematology, ISSN 1865-3774. 97(2013), 6, Seite 765-772
DOI: 10.1007/s12185-013-1320-1
Raab, Marc-Steffen: GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo / Marc S. Raab, Iris Breitkreutz, Simon Anderhub, Mads H. Rønnest, Blanka Leber, Thomas O. Larsen, Lud… , October 2012. - 12 S.
In: Cancer research, ISSN 1538-7445. 72(2012), 20, Seite 5374-5385
DOI: 10.1158/0008-5472.CAN-12-2026
Vulprecht, Julia: STIL is required for centriole duplication in human cells / Julia Vulprecht, Ahuvit David, Alexandra Tibelius, Asher Castiel, Gleb Konotop, Fengying Liu, Felix … , April 6, 2012. - 10 S.
In: Journal of cell science, ISSN 1477-9137. 125(2012), 5, Seite 1353-1362
DOI: 10.1242/jcs.104109
Neben, Kai: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p / Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Hans Sa… , January 26, 2012. - 9 S.
In: Blood, ISSN 1528-0020. 119(2012), 4, Seite 940-948
DOI: 10.1182/blood-2011-09-379164
Neben, Kai: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p / Kai Neben ... Anna Jauch; Uta Bertsch ... Marc S. Raab; Anthony D. Ho ... Dirk Hose ... Hartmut Gold… , 2012. - 9 S.
In: Blood, ISSN 0006-4971. 119(2012), 4, Seite 940-948
Klein, Ulrike: Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone / Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose… , 2011. - 9 S.
In: Cancer, ISSN 1097-0142. 117(2011), 10, Seite 2136-2144
DOI: 10.1002/cncr.25775
Rønnest, Mads H.: Disparate SAR data of Griseofulvin analogues for the dermatophytes trichophyton mentagrophytes, T. rubrum, and MDA-MB-231 cancer cells / Mads H. Rønnest, Marc S. Raab, Simon Anderhub, Sven Boesen, Alwin Krämer, Thomas O. Larsen and Mads … . - 9 S.
In: Journal of medicinal chemistry, ISSN 1520-4804. 55(2012), 2, S. 652-660
DOI: 10.1021/jm200835c
Weinhold, Niels: NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm / Niels Weinhold, Jerome Moreaux, Marc S. Raab, Dirk Hose, Thomas Hielscher, Axel Benner, Tobias Meißn… , 13 January 2010. - 9 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 49(2010), 4, Seite 333-341
DOI: 10.1002/gcc.20745
Neben, Kai: Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation / Kai Neben, Anna Jauch, Uta Bertsch, Christiane Heiss, Thomas Hielscher, Anja Seckinger, Tina Mors, N… , 2010 Jul. - 8 S. : Diagramme
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 7, Seite 1150-1157
DOI: 10.3324/haematol.2009.016436
Breitkreutz, Iris: Thalidomide in newly diagnosed multiple myeloma : influence of thalidomide treatment on peripheral blood stem cell collection yield / I. Breitkreutz, H.M. Lokhorst, M.S. Raab, B. van der Holt, F.W. Cremer, D. Herrmann, A. Glasmacher, … , 22 March 2007. - 6 S.
In: Leukemia, ISSN 1476-5551. 21(2007), 6, Seite 1294-1299
DOI: 10.1038/sj.leu.2404661
Hundemer, Michael: Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14) / M. Hundemer, U. Klein, D. Hose, M.-S. Raab, F. W. Cremer, A. Jauch, A. Benner, C. Heiss, M. Moos, A.… , 24 September 2007. - 5 S. : Diagramme
In: Bone marrow transplantation, ISSN 1476-5365. 40(2007), 11, Seite 1033-1037
DOI: 10.1038/sj.bmt.1705857
Raab, Marc-Steffen: The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure / Marc S. Raab, Iris Breitkreutz, Michael Hundemer, Axel Benner, Jens Klaus, Ute Hegenbart, Thomas Moe… , [November, 2006]. - 4 S. : Diagramme
In: Haematologica, the hematology journal, ISSN 1592-8721. 91(2006), 11 vom: Nov., Seite 1555-1558
DOI: 10.3324/%x
Mahtouk, Karène: Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells / Karène Mahtouk, Dirk Hose, Thierry Rème, John De Vos, Michel Jourdan, Jérôme Moreaux, Geneviève Fiol… , 28 February 2005. - 13 S.
In: Oncogene, ISSN 1476-5594. 24(2005), 21 vom: Feb., Seite 3512-3524
DOI: 10.1038/sj.onc.1208536
Raab, Marc-Steffen: Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma / M.S. Raab, F.W. Cremer, I.N. Breitkreutz, S. Gerull, T. Luft, A. Benner, M. Goerner, A.D. Ho, H. Gol… , 28 February 2005. - 7 S. : Diagramme
In: Annals of oncology, ISSN 1569-8041. 16(2005), 4 vom: Feb., Seite 611-617
DOI: 10.1093/annonc/mdi123
Moreaux, Jérôme: The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature / Jérôme Moreaux, Friedrich W. Cremer, Thierry Reme, Marc Raab, Karene Mahtouk, Philine Kaukel, Veroni… , [August 1 2005]. - 10 S. : Illustrationen
In: Blood, ISSN 1528-0020. 106(2005), 3 vom: Aug., Seite 1021-1030
DOI: 10.1182/blood-2004-11-4512
Cremer, Friedrich Walter: High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH / Friedrich W. Cremer, Mutlu Kartal, Dirk Hose, Jelena Bila, Isabelle Buck, Frauke Bellos, Marc-Steffe… , [September 2005]. - 9 S. : Illustrationen
In: Cancer genetics and cytogenetics, ISSN 1873-4456. 161(2005), 2 vom: Sept., Seite 116-124
DOI: 10.1016/j.cancergencyto.2005.02.015
Cremer, Friedrich Walter: Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics / Friedrich W. Cremer, Jelena Bila, Isabelle Buck, Mutlu Kartal, Dirk Hose, Carina Ittrich, Axel Benne… , 06 July 2005. - 10 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 44(2005), 2, Seite 194-203
DOI: 10.1002/gcc.20231

IDs

GND:

124052460

Links

Raab, Marc-Steffen in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design